Back to Search

ABDELSALAM SHARABI, M.D.

M.D.

Anatomic Pathology & Clinical Pathology Physician

NPI: 1922043850IndividualAccepts Medicare

Specialties, Licenses & Credentials

Anatomic Pathology & Clinical Pathology PhysicianPrimary

Pathology — Anatomic Pathology & Clinical Pathology

Code: 207ZP0102X

234557(NY)
Hematology (Pathology) Physician

Pathology — Hematology

Code: 207ZH0000X

234557(NY)

CMS Specialties

PrimaryPATHOLOGY

Education

OTHER

Class of 1989

Research & Publications (20)

Bcl-xL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptide.
PMID 19596183·J Autoimmun·2010
7-preclinical
Embryonic stem cells and mammary luminal progenitors directly sense and respond to microbial products.
PMID 19544467·Stem Cells·2009
7-preclinical
A tolerogenic peptide that induces suppressor of cytokine signaling (SOCS)-1 restores the aberrant control of IFN-gamma signaling in lupus-affected (NZB x NZW)F1 mice.
PMID 19631585·Clin Immunol·2009
7-preclinical
Treatment of lupus patients with a tolerogenic peptide, hCDR1 (Edratide): immunomodulation of gene expression.
PMID 19346102·J Autoimmun·2009
8-other
The tolerogenic peptide hCDR1 downregulates pathogenic cytokines and apoptosis and upregulates immunosuppressive molecules and regulatory T cells in peripheral blood mononuclear cells of lupus patients.
PMID 19280712·Hum Immunol·2009
8-other
B-cell activating factor (BAFF) plays a role in the mechanism of action of a tolerogenic peptide that ameliorates lupus.
PMID 19188092·Clin Immunol·2009
7-preclinical
The role of dendritic cells in the mechanism of action of a peptide that ameliorates lupus in murine models.
PMID 19040426·Immunology·2009
7-preclinical
A novel synthetic peptide for the specific treatment of lupus: clinical effects and mechanism of action.
PMID 18300570·Isr Med Assoc J·2008
6-review
The suppression of murine lupus by a tolerogenic peptide involves foxp3-expressing CD8 cells that are required for the optimal induction and function of foxp3-expressing CD4 cells.
PMID 18713995·J Immunol·2008
7-preclinical
Twist-2 controls myeloid lineage development and function.
PMID 19090621·PLoS Biol·2008
7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

Contact & Hours

Address
10 NATHAN D PERLMAN PLACE, SUITE 12S34
NEW YORK, NY 10003

Quick Facts

NPI
1922043850
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
2
Locations
1
Years in Practice
37
Publications
20

Are you this provider?

Claim Your Profile